ATE413893T1 - Wundverband enthaltend komplexe von vanadat und organische verbindungen - Google Patents

Wundverband enthaltend komplexe von vanadat und organische verbindungen

Info

Publication number
ATE413893T1
ATE413893T1 AT03767966T AT03767966T ATE413893T1 AT E413893 T1 ATE413893 T1 AT E413893T1 AT 03767966 T AT03767966 T AT 03767966T AT 03767966 T AT03767966 T AT 03767966T AT E413893 T1 ATE413893 T1 AT E413893T1
Authority
AT
Austria
Prior art keywords
vanadate
organic compounds
wound dressing
containing complexes
dressing containing
Prior art date
Application number
AT03767966T
Other languages
English (en)
Inventor
Patrick Trotter
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Application granted granted Critical
Publication of ATE413893T1 publication Critical patent/ATE413893T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT03767966T 2002-12-12 2003-12-08 Wundverband enthaltend komplexe von vanadat und organische verbindungen ATE413893T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0229012A GB2396106B (en) 2002-12-12 2002-12-12 Wound dressings comprising enzyme inhibitors

Publications (1)

Publication Number Publication Date
ATE413893T1 true ATE413893T1 (de) 2008-11-15

Family

ID=9949580

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767966T ATE413893T1 (de) 2002-12-12 2003-12-08 Wundverband enthaltend komplexe von vanadat und organische verbindungen

Country Status (7)

Country Link
US (1) US20060165761A1 (de)
EP (1) EP1569697B1 (de)
AT (1) ATE413893T1 (de)
AU (1) AU2003292389A1 (de)
DE (1) DE60324704D1 (de)
GB (1) GB2396106B (de)
WO (1) WO2004052412A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328157D0 (en) * 2003-12-04 2004-01-07 Imp College Innovations Ltd Compounds
US9463119B2 (en) 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
EP1949894B1 (de) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Verstärkung von vanadiumhaltigen Phosphatasehemmern mit Polyole
US8008035B2 (en) * 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
DK3441054T3 (da) * 2007-11-05 2020-11-09 Abigo Medical Ab Indretning til behandling af vaginal svampeinfektion
US8263115B2 (en) * 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
GB201103898D0 (en) * 2011-03-08 2011-04-20 Univ Cardiff Molecular targets for healing or treating wounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300496A (en) * 1991-09-30 1994-04-05 The University Of British Columbia Complexed vanadium for the treatment of diabetes mellitus
GB9323884D0 (en) * 1993-11-19 1994-01-05 Eisai London Res Lab Ltd Physiological modulation
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5741777A (en) * 1995-10-31 1998-04-21 Board Of Regents, The University Of Texas System Modulation of wound contraction by blocking protein tyrosine phosphatase
US20020019412A1 (en) * 1998-03-12 2002-02-14 Henrik Sune Andersen Modulators of protein tyrosine phosphatases (ptpases)

Also Published As

Publication number Publication date
GB2396106B (en) 2006-11-15
GB0229012D0 (en) 2003-01-15
EP1569697A1 (de) 2005-09-07
EP1569697B1 (de) 2008-11-12
US20060165761A1 (en) 2006-07-27
AU2003292389A1 (en) 2004-06-30
WO2004052412A1 (en) 2004-06-24
GB2396106A (en) 2004-06-16
DE60324704D1 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
TR199801569T2 (xx) Serin proteaz inhibit�rleri.
SE9701162D0 (sv) New use II
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
DE60130976D1 (de) Dosierschema enthaldend farnesyl protein transferase inhibitoren für die behandlung von krebs
DE69813241T2 (de) Vielschichtiger wundverband
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69836563D1 (de) INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN
EA200701467A1 (ru) Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
BG106242A (en) Metalloprotease inhibitors
ATE399547T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
ATE413893T1 (de) Wundverband enthaltend komplexe von vanadat und organische verbindungen
DE60212613D1 (de) Doxycyclin zur behandlung von akne
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
ATE181925T1 (de) Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
TR199801705T2 (xx) Serin proteaz inhibit�rleri.
DE60113252D1 (de) Inhibitoren von serin proteasen
BR9813778A (pt) Utilização de pelo menos um fucano.
DE602004031954D1 (de) Verbindungen zur behandlung von stoffwechselstörungen
DE60334830D1 (de) Furin-hemmer zur behandlung von fibrose und narbenbildung
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ATE228840T1 (de) Neue verwendung von ropivacain zur schmerzbehandlung
ATE337004T1 (de) Verwendung von mangafodipir zur behandlung der hepatozellularen insuffizienz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties